{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:21:37Z","timestamp":1767961297417,"version":"3.49.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.biologicals.2004.03.002","type":"journal-article","created":{"date-parts":[[2004,11,3]],"date-time":"2004-11-03T17:09:46Z","timestamp":1099501786000},"page":"157-163","source":"Crossref","is-referenced-by-count":15,"title":["Validation of an anti-PA-ELISA for the potency testing of anthrax vaccine in mice"],"prefix":"10.1016","volume":"32","author":[{"given":"Mar\u00eda","family":"Pombo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Berthold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Gingrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Leef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lev","family":"Sirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Arciniega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2004.03.002_bib1","unstructured":"21 CFR Part 620.20. Food and drug administration, HHS. Code of Federal Regulation. Subpart C \u2013 anthrax vaccine adsorbed [chapter I]; 4-1-92. p. 71\u20132."},{"key":"10.1016\/j.biologicals.2004.03.002_bib2","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine. Evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"Friedlander","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.biologicals.2004.03.002_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1365-2672.2001.01498.x","article-title":"The development of new vaccines against Bacillus anthracis","volume":"91","author":"Baillie","year":"2001","journal-title":"J Appl Environ Microbiol"},{"key":"10.1016\/j.biologicals.2004.03.002_bib4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2004.03.002_bib5","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.1016\/S0021-9258(17)32036-7","article-title":"Anthrax protective antigen forms oligomers during intoxication of mammalian cells","volume":"269","author":"Milne","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2004.03.002_bib6","series-title":"The principles of humane experimental technique","author":"Russell","year":"1959"},{"key":"10.1016\/j.biologicals.2004.03.002_bib7","unstructured":"ICH. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Text on validation of analytical procedures; 1994. p. 1\u20135."},{"key":"10.1016\/j.biologicals.2004.03.002_bib8","unstructured":"The United States Pharmacopeia. USP 26. General information <1225>,validation of compendial methods; 2003. p. 2439\u201342."},{"key":"10.1016\/j.biologicals.2004.03.002_bib9","unstructured":"U.S. Food and Drug Administration. Guidance for industry: manufacturing, processing, or holding active pharmaceutical ingredients; March 1998."},{"key":"10.1016\/j.biologicals.2004.03.002_bib10","unstructured":"U.S. Food and Drug Administration. Guidelines on general principles of process validation; May 1987."},{"key":"10.1016\/j.biologicals.2004.03.002_bib11","unstructured":"ICH. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Validation of analytical procedures: methodology; 1996. p. 1\u20138."},{"key":"10.1016\/j.biologicals.2004.03.002_bib12","first-page":"103","article-title":"Production and purification of anthrax toxin","volume":"165","author":"Leppla","year":"1991"},{"key":"10.1016\/j.biologicals.2004.03.002_bib13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CDLI.3.6.689-700.1996","article-title":"Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens","volume":"3","author":"Lynn","year":"1996","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105604000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105604000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T14:45:25Z","timestamp":1624805125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105604000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1045105604000454"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2004.03.002","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}